Hormone therapy can change a life that has slowly shrunk around fatigue, brain fog, hot flashes, low libido, weight gain, or low mood. It can also go poorly if a clinic rushes to prescribe, ignores your history, or promises more than physiology can deliver. I have seen both ends of the spectrum. Patients who start with a clear diagnosis and a careful plan usually do well. Patients who jump into aggressive dosing, pellet implants without proper screening, or complicated compounded regimens with no monitoring often circle back months later with side effects and a lighter wallet.
The goal of this checklist is to help you interview a hormone clinic, clarify whether you are a good candidate for hormone treatment, and understand trade-offs before you commit. The right hormone doctor will welcome these questions and answer them with precision, not sales language.
What responsible hormone care looks like
Good hormone care starts with a diagnosis. That sounds obvious, but it is surprising how many clinics skip right to a protocol. Your clinician should ask about symptom patterns, medical history, medications, pregnancy history if relevant, family history of cancers and clotting, and sleep and lifestyle. They should confirm a hormone imbalance with appropriate lab work, then explain how your symptoms connect to your results. If your labs are normal, they should discuss other causes and whether watchful waiting, lifestyle changes, or nonhormonal options might help.
Equally important, the plan should be individualized. Menopause hormone therapy is not the same as testosterone replacement therapy. Thyroid hormone replacement is not weight loss medicine. Gender-affirming hormone therapy requires different targets and timelines. A good hormone specialist will distinguish evidence-based treatment for a specific deficiency from general hormone optimization that promises to fix everything.
Start with goals you can measure
Before therapy, you and your clinician should define what success looks like. Relief of hot flashes within 2 to 6 weeks, fewer night sweats, more stable mood, or improved sleep are concrete targets for estrogen and progesterone therapy. For low testosterone treatment, you might look for better morning energy, libido, and exercise recovery over 6 to 12 weeks, paired with testosterone levels that land in the lab’s reference range. For thyroid hormone therapy, the aim is resolution of hypothyroid symptoms and a TSH in the target zone, often around 0.5 to 2.5 mIU/L for many patients, though goals vary by age and comorbidity.
These goals keep the team honest. If symptoms do not shift as expected despite therapeutic hormone levels, the clinic should reassess the diagnosis rather than layer on more hormones.
Testing that should come before a prescription
Baseline labs depend on the therapy. Your hormone clinic should spell out a testing plan that aligns with guidelines, your symptoms, and safety.
For menopause and perimenopause hormone therapy, lab tests are often less important than history and symptom timing. In women over 45 with classic vasomotor symptoms, clinicians can usually diagnose menopause clinically. That said, baseline lipids, liver function, and blood pressure matter for risk assessment. If menstrual cycles are erratic or early menopause is suspected, FSH and estradiol can help clarify. If you have a uterus and will use estrogen, progesterone will be part of the regimen to protect the endometrium.
For testosterone therapy in men, low testosterone should be confirmed with at least two early morning total testosterone measurements, drawn on separate days. The clinic should also check LH, FSH, prolactin if appropriate, a complete blood count to capture hematocrit, and PSA with a prostate exam if age and risk suggest it. If fertility is a goal, testosterone replacement may not be the right tool, and a reproductive urologist should be involved.
For gender-affirming hormone therapy, a clinic should follow established protocols for transgender hormone treatment. Baseline labs commonly include estradiol and testosterone, a complete blood count, liver function, lipids, and prolactin for transfeminine patients. For transmasculine patients, baseline testosterone, hematocrit, liver function, and lipids are standard. Targets differ: many clinicians aim for estradiol roughly 100 to 200 pg/mL with testosterone less than 50 ng/dL for MTF hormone therapy, and for testosterone around 400 to 700 ng/dL for FTM hormone therapy. Exact targets and timing vary by program and patient needs.
For thyroid hormone replacement, TSH and free T4 are the backbone. In suspected central hypothyroidism, free T4 drives decisions more than TSH. Thyroid antibodies help determine if autoimmune thyroiditis is in play. Be cautious with clinics that recommend thyroid hormone for nonspecific symptoms when TSH and free T4 are normal.
For growth hormone therapy, adult HGH therapy requires firm evidence of deficiency on stimulation testing. Random IGF-1 levels alone are not enough, because they vary with nutrition, liver function, and age. HGH therapy can cause fluid retention, joint pain, and insulin resistance, so it should not be offered for general anti-aging goals.
For DHEA or adrenal hormone therapy, be wary. True adrenal insufficiency should be diagnosed with morning cortisol and ACTH testing, sometimes with a stimulation test. Adrenal fatigue is not a recognized diagnosis. Unsupervised cortisol treatment can cause serious harm.
Choosing a treatment modality, and the trade-offs
Once you have a diagnosis, you will face choices. The routes and formulations matter for both benefit and risk.
Estrogen therapy. Transdermal estradiol patches, gels, or sprays generally have a lower risk of blood clots and stroke than oral estrogen. Oral estrogen can raise triglycerides and affect clotting factors, which is relevant if you have a history of migraine with aura, clotting disorders, or high cardiovascular risk. If you have a uterus, add progesterone therapy for endometrial protection. Many women do well with micronized progesterone at bedtime, which has a favorable side effect profile and may aid sleep. Some patients need combined estrogen and progesterone therapy year-round, others use cyclical dosing. Doses are adjusted to the lowest effective amount, with regular reassessment.
Progesterone options. Micronized progesterone is bioidentical and commonly used with transdermal estradiol. Some clinics prefer synthetic progestins for specific indications. Evidence suggests different progestogens carry different risks and side effect profiles. If you notice mood changes or bloating on one option, ask to try another.
Testosterone therapy for men. Options include topical gels, weekly or twice-weekly injections, longer-acting injections, or pellet hormone therapy. Gels allow fine-tuning but can transfer to others with skin contact. Injections are reliable and cost-effective, but dosing intervals matter to avoid peaks and troughs. Pellets provide steady levels for months, but dose adjustment is slow and minor surgical insertion is required each time. Be clear about goals. Testosterone optimization should relieve symptoms and keep levels in the normal range. Pushing levels well above the upper limit increases risks without proven long-term benefit.
Testosterone therapy for women is most often used off-label for hypoactive sexual desire disorder in postmenopausal women, at very low doses. Data are more limited, compounding is common, and careful monitoring for acne, hair growth, and voice changes is mandatory. If a clinic proposes high-dose testosterone for weight loss or general vitality in women, ask for evidence.
Gender-affirming hormone therapy. For transfeminine patients, estradiol is often combined with an antiandrogen such as spironolactone, especially early on, or with GnRH analogs when accessible. For transmasculine patients, testosterone can be delivered via injections, gels, or patches. The clinic should outline realistic timelines for changes, from skin oiliness in weeks to voice changes or body fat redistribution over months. Fertility preservation should be discussed before starting.
Bioidentical hormones and compounded therapy. Bioidentical simply means the hormone molecule matches what the body produces, such as estradiol and micronized progesterone. Many FDA-approved products are bioidentical. Compounded bioidentical hormones may be needed if you are allergic to an ingredient or require a dose not commercially available. They can be helpful, but quality depends on the compounding pharmacy. In general, prefer FDA-approved products when possible, then use compounded options thoughtfully with a reputable pharmacy that provides certificates of analysis.
Synthetic hormone therapy. Some synthetic formulations, like certain progestins, remain widely used and can be appropriate for some patients. Do not equate synthetic with bad and bioidentical with perfect. Each product has a risk, benefit, and cost profile.
Safety first: who should not start therapy, and what to monitor
No therapy is risk-free. The clinic should review absolute and relative contraindications, and document informed consent.
For estrogen replacement therapy, avoid systemic estrogen if you have a history of estrogen-sensitive breast cancer unless your oncology team is involved. Past blood clots, stroke, or certain clotting disorders complicate use, although transdermal routes may be safer for some. Active liver disease and unexplained vaginal bleeding require evaluation. Starting HRT within 10 years of menopause onset or before age 60 generally offers a better balance of benefit to risk for vasomotor symptoms. Cardiovascular risk and breast cancer risk should be personalized rather than guessed.
For progesterone treatment, watch for mood changes or sedation, especially at higher doses. Unexplained bleeding needs assessment to rule out endometrial pathology.
For testosterone replacement therapy in men, erythrocytosis is common. A hematocrit above about 54 percent typically triggers dose reduction or a pause. Monitoring PSA and prostate health is vital, particularly in older men or those with risk factors. Testosterone suppresses sperm production. If you hope to conceive in the near future, consider alternatives like selective estrogen receptor modulators under a specialist’s care. Acne, hair loss, and sleep apnea can worsen on TRT. Blood pressure and lipids need attention.
For thyroid hormone, overtreatment can thin bones and provoke arrhythmias, especially in older adults. If your TSH drops below the lab reference range without a clear reason, the dose is likely too high.
For growth hormone therapy, edema, joint aches, carpal tunnel symptoms, and effects on glucose tolerance can occur. Because long-term risks depend on patient factors, therapy belongs under an endocrinologist’s guidance.
Monitoring that keeps you safe and on track
A clinic should give you a specific follow-up schedule. After starting or changing a dose, most therapies need reassessment at 6 to 12 weeks, then every 3 to 6 months in the first year, and at least annually once stable. For menopause HRT, visits often include symptom review, blood pressure, and side effect checks. For TRT and FTM hormone therapy, check testosterone at the appropriate time relative to dosing, hematocrit, and, if indicated, lipids and liver enzymes. For MTF hormone therapy, recheck estradiol and testosterone, watch potassium if on spironolactone, and track prolactin when clinically relevant. For thyroid hormone, repeat TSH and free T4 four to eight weeks after a change.
The point is not to chase perfect numbers, but to balance symptom relief with levels in a safe physiological range.
The five questions I would ask any hormone clinic
- How do you confirm the diagnosis before prescribing, and what baseline labs will you order for my case? Which products and routes do you prefer first, and why those over the alternatives for me? What are the specific risks in my situation, and what is your monitoring schedule to catch problems early? How do you handle dose adjustments, side effects, and questions between visits, and what will my out-of-pocket costs look like over 12 months? Do you use FDA-approved medications when possible, and if compounding is needed, which pharmacy do you trust and how do you verify quality?
If a clinic gives vague, one-size-fits-all answers, keep looking.
Red flags that deserve a hard pause
- Promises of weight loss, perfect sleep, and disease prevention for everyone on hormone optimization without solid evidence that fits your case. Refusal to coordinate with your primary care clinician or specialists, or discouraging cancer screening and routine care. Pellet hormone therapy offered as the only option, with no discussion of reversible alternatives or monitoring of levels after insertion. A plan to treat “adrenal fatigue” with cortisol without proper testing, or a willingness to prescribe HGH therapy based on a single IGF-1 level. Locked-in, prepaid packages that make it hard to leave if you do not improve or you develop side effects.
Costs, access, and practicalities
Insurance coverage varies. FDA-approved estradiol patches and micronized progesterone are often covered with a copay, though some plans require prior authorization. Compounded bioidentical hormones are usually cash pay. Testosterone injections are usually affordable even without coverage, while some topical products and long-acting formulations can be costly. Pellet hormone implants often involve a procedure fee plus the product, and insurance rarely covers them.
Ask for a 12‑month cost forecast that includes clinic visits, labs, and medications. Telemedicine can be convenient, but ask how labs and urgent issues are handled across state lines. Make sure the clinic can help you taper or transition care if you move.
Nuances by population
Menopause and perimenopause. Perimenopause can be bumpy, with fluctuating estrogen and progesterone. Low-dose combined hormonal contraceptives, transdermal estradiol with cyclic progesterone, or nonhormonal options like SSRIs may each play a role at different stages. Vaginal estrogen, which has minimal systemic absorption, is effective for genitourinary symptoms and is safe for many women who cannot take systemic estrogen. For women within 10 years of their final period who are otherwise healthy, hormone therapy is a reasonable option for moderate to severe vasomotor symptoms. If you started HRT years after menopause, discuss cardiovascular risk carefully.
Low T treatment for men. Not every man with a low morning testosterone is a candidate for TRT. Obesity, sleep apnea, heavy alcohol use, certain medications, and acute illness can transiently lower levels. Addressing those can raise testosterone without replacement. When TRT is appropriate, setting a target window, often mid-normal, and choosing a route that fits your routine improves adherence and outcomes.
Gender-affirming hormone therapy. This is gender-affirming care first, hormone therapy second. A respectful clinic will use an informed consent model, discuss fertility preservation before starting, and set realistic timelines for physical and emotional changes. Mental health support, primary care coordination, and voice or hair services often become part of the plan. Monitoring is similar to other hormone care, with attention to blood pressure, hematocrit or potassium depending on the regimen, and screening appropriate to organs present.
Thyroid hormone replacement. Many patients feel better with consistent dosing and stable routines. Take levothyroxine on an empty stomach, away from iron, calcium, and some supplements and medications. Combination T4/T3 therapy may help a subset of patients, but it requires careful selection and monitoring to avoid overtreatment. Be skeptical of clinics that push high-dose T3 for fatigue without a clear rationale.
Adrenal and DHEA. DHEA therapy can modestly raise androgen levels but is not a fix-all. Cortisol replacement is only for proven adrenal insufficiency. If a clinic suggests cortisol treatment for stress, that is a red flag.
Lifestyle belongs in the plan
Sleep, nutrition, resistance training, and alcohol moderation profoundly affect hormone signaling and symptoms. I have seen a patient’s hematocrit normalize on TRT after she fixed undiagnosed sleep apnea. I have watched hot flashes drop by half when caffeine and alcohol intake were reduced and regular exercise returned. A strong clinic will incorporate these levers. Hormones are not a substitute for basics, they are a tool that works best on a solid foundation.
How dose adjustments really happen
Expect small, steady changes rather than sudden jumps. A typical path for TRT might start with weekly injections, measure trough or midpoint levels after six weeks, note symptoms, and adjust by 10 to 20 percent if needed. For estradiol patches, many women need one or two adjustments to settle vasomotor symptoms without breast tenderness. For progesterone-induced drowsiness, shifting dosing to bedtime or adjusting milligrams solves it. Good clinicians listen first, then touch the dial.
Consent, communication, and data security
You should receive written information outlining benefits, risks, and alternatives. Your consent should be documented. The clinic’s patient portal should let you see lab results, send messages, and access visit notes. For compounded hormone therapy, ask for the compounding pharmacy’s accreditation and quality standards. For hormone pellet therapy, ask how they will respond if your levels overshoot. Clinics that take consent and communication seriously are the same clinics that catch problems early.
Preparing for your first visit
Bring a symptom timeline, even if it is rough. Include approximate onset and any patterns, such as worse hot flashes after wine or bigger energy dips with poor sleep. List your medications and supplements. If you have had labs in the last year, bring copies. If you have a strong family history of breast or prostate cancer, bring those details. Write down what a win looks like in 3 and 6 months. These simple steps make the visit more productive and reduce the chance of a misfire.
Where integrative and functional perspectives fit
An integrative Go to this website approach can add value when it stays grounded. Vitamin D sufficiency, iron status, and B12 matter for fatigue. Cognitive behavioral therapy and paced breathing techniques can lower the perceived intensity of hot flashes for some women. Resistance training and protein optimization help preserve muscle during menopause and on TRT. Just keep the hierarchy clear. Use hormone therapy when indicated, choose products with the strongest safety and efficacy data, and reserve compounded or experimental regimens for true edge cases.
Final thoughts to carry into the consult
Hormone therapy is powerful. Bioidentical hormones, testosterone injections, estrogen and progesterone therapy, even thyroid hormone replacement can restore the texture of daily life when used for the right reasons. The right hormone clinic pairs that power with restraint. They test when needed, start low, monitor closely, pivot when reality contradicts the plan, and keep you, not the protocol, at the center.
If you ask sharp questions, compare answers across clinics, and insist on a monitoring plan you understand, you will make a safer, more effective start. The payoff is not just better numbers on a lab report. It is waking up and recognizing yourself again.